Please fill in the form with your username, your password will be send to your registered e-mail.
* Mandatory fields
Website dedicated to help patients, their family and friends about the cancer immunotherapeutic approach in an easy-to-understand format.
Website providing information about the now recruiting Non-Small Cell Lung Cancer phase III clinical study
This section is devoted to the ability of the immune system to protect against cancer. When tumor antigens are taken up by antigen-presenting cells (APC), they are processed and epitopes are presented to T-cells in association with the major histocompatibility complex (MHC) molecule. The aim of specific cancer immunotherapies, including ASCI, is to stimulate and enhance this natural immune response, to effectively kill tumor cells.
If this is your first time at this site, please click here to register.
Register now
For legal reasons, this page is intended solely for healthcare professionals. This is why we ask you to register.
© 2001 - 2008 GlaxoSmithKline plc. All rights reserved.